Denali Therapeutics Inc Equity-NMS: DNLI

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$38.11

52W high :

$56.8

1Y :

-27.76%

5Y :

67.73%

EPS(TTM): :

-2.32

Shares O/S :

123.35 M

Market cap :

4.64 B

What is the share price of Denali Therapeutics Inc today?

Denali Therapeutics Inc (DNLI) share price as of August 15, 2022, is $37.61. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Denali Therapeutics Inc?

Yes, Indian Investors can invest in the Denali Therapeutics Inc (DNLI) Share by opening an international trading account with Angel One.

How can I purchase Denali Therapeutics Inc shares in India?

Purchasing Denali Therapeutics Inc (DNLI) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Denali Therapeutics Inc (DNLI) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Denali Therapeutics Inc?

Yes, you can purchase fractional shares of Denali Therapeutics Inc (DNLI) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Denali Therapeutics Inc?

The market capitalization of Denali Therapeutics Inc on August 16, 2022, is $4.64 B.

In which sector Denali Therapeutics Inc belongs?

Denali Therapeutics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Denali Therapeutics Inc stocks?

In order to invest in Denali Therapeutics Inc (DNLI) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company clinical programs include leucine-rich repeat kinase 2 (LRRK2) inhibitor program, eukaryotic initiation factor 2 B (EIF2B) activator program, enzyme transport vehicle: iduronate 2-sulfatase (ETV:IDS) program, receptor interacting serine/threonine protein kinase 1 (RIPK1) inhibitor program and second non-CNS penetrant RIPK1 inhibitor. The Company engineers its product candidates to cross the blood-brain barrier (BBB), and act directly in the brain. Its pipeline includes approximately 15 programs that are based on its TV technology, including the lead program ETV:IDS (DNL310). Its product pipeline includes DNL151, DNL593 (PTV:PGRN), DNL126 (ETV:SGSH), DNL919 (ATV:TREM2), DNL788, DNL343, DNL758 and others.